Company Filing History:
3 out of 2,613 
2 out of 87 
1 out of 1 Years Active: 2022-2025
Title: Pilhan Kim – Innovator in Anti-Angiopoietin-2 Antibodies
Introduction
Pilhan Kim is an accomplished inventor based in Daejeon, South Korea, recognized for his significant contributions to the field of therapeutic antibodies. He holds one patent, which showcases his innovative spirit and commitment to advancing medical science.
Latest Patents
His sole patent, titled "Anti-angiopoietin-2 antibodies that induce Tie2 activation," revolves around mouse antibodies that bind to angiopoietin-2 (Ang2). This invention encompasses humanized anti-Ang2 antibodies derived from the mouse antibodies, emphasizing their dual function of activating the Tie2 receptor while neutralizing Ang2. The significance of these anti-Ang2 antibodies lies in their ability to normalize abnormal and pathological blood vessels, presenting therapeutic efficacy against a range of diseases and disorders linked to abnormal blood vessel function. Furthermore, the invention provides an angiogenesis inhibitor and a composition for treating conditions related to abnormal Ang2 expression and Tie2 dysregulation, incorporating the antibody as an active ingredient. Additionally, it includes diagnostics for diseases characterized by Ang2 inhibition and Tie2 activation, utilizing the antibody for this purpose.
Career Highlights
Pilhan Kim has made notable strides in his career, with significant experience at leading research institutions such as the Institute for Basic Science and the Korea Advanced Institute of Science and Technology. His tenure at these esteemed organizations has no doubt contributed to his innovative research and the development of impactful medical therapies.
Collaborations
Throughout his career, Pilhan Kim has collaborated with esteemed colleagues including Gou Young Koh and Jeomil Bae. These professional partnerships have played a critical role in advancing his research and honing his expertise in the field of biotechnology.
Conclusion
In conclusion, Pilhan Kim exemplifies the spirit of innovation in the realm of therapeutic antibodies with his pioneering work on anti-angiopoietin-2 antibodies. His patent highlights the potential for significant advancements in treating diseases associated with blood vessel abnormalities, showcasing the profound impact that dedicated inventors can have on medical and scientific progress.